department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Chewtadzy · pharmadog

pharmadog
drugs
Chewtadzy

drug

patient view →

Chewtadzy

Marketedupdated 2mo ago

by $ANIP ANI PHARMACEUTICALS INC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Chewtadzy

generic

tadalafil

indication

Storage Symptoms of Benign Prostatic Hyperplasia

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 24, 2038

~12.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Dec 24, 2038formulationUS 11382917
Dec 24, 2038formulationUS 11666576
Dec 24, 2038formulationUS 11975006
Dec 24, 2038formulationUS 12186322

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

drugtadalafil6 co-mentions · 6 sources
tagRecall6 co-mentions · 6 sources
drugAdcirca6 co-mentions · 6 sources
drugCelebrex4 co-mentions · 2 sources
drugcelecoxib SR4 co-mentions · 2 sources
drugElyxyb4 co-mentions · 2 sources
drugCELECOXIB4 co-mentions · 2 sources
companyAlembic Pharmaceuticals Inc3 co-mentions · 1 sources

Trials studying Chewtadzy

phase3A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Optionrecruitingn=280
phase3Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)completedn=187
phase1Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subjectnot yet recruitingn=72
phase1A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjectscompletedn=38
EP1Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neckcompletedn=50
phase3The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertensioncompletedn=247
phase1A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participantscompletedn=40
phase1A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafilcompletedn=18

more trials →